PROCEPT BioRobotics Corporation
US ˙ NasdaqGM ˙ US74276L1052

Introduzione

Questa pagina fornisce un'analisi completa dello storico delle operazioni di insider trading note di CPMG Inc. Gli insider sono funzionari, direttori o investitori importanti di una società. In generale, è illegale per gli insider effettuare operazioni di compravendita nelle loro aziende sulla base di informazioni materiali non pubbliche. Ciò non significa che sia illegale per loro effettuare qualsiasi operazioni di trading nelle proprie aziende. Tuttavia, devono segnalare tutte le operazioni alla SEC tramite un modulo 4. Nonostante queste restrizioni, la ricerca accademica suggerisce che gli insider, in generale, tendono a sovraperformare il mercato nelle proprie società.

Redditività media delle transazioni

La redditività media delle transazioni è il rendimento medio di tutti gli acquisti effettuati sul mercato aperto dagli insider negli ultimi tre anni. Pe calcolarla, esaminiamo tutti gli acquisti non pianificati effettuati dall'insider sul mercato aperto, escludendo tutte le operazioni che sono state parte di un piano di trading 10b5-1. Calcoliamo quindi la performance media di queste operazioni nell'arco di 3, 6 e 12 mesi e facciamo la media di ciascuna di queste durate per generare un indicatore di performance finale per ogni operazione. Infine, facciamo la media di tutti gli indicatori di performance per calcolare un indicatore di performance per l'insider. Questo elenco comprende solo gli insider che hanno effettuato almeno tre operazioni negli ultimi due anni.

Se la redditività delle operazioni di questo insider è "N/D", l'insider non ha effettuato acquisti sul mercato aperto negli ultimi tre anni, oppure le operazioni effettuate sono troppo recenti per poter calcolare un indicatore di performance affidabile.

Frequenza di aggiornamento: giornaliera

Vedi l'elenco degli insider trader più redditizi

Società con posizioni di insider dichiarate

I depositi SEC indicano che CPMG Inc ha dichiarato partecipazioni o transazioni nelle seguenti società:

Titolo Ruolo Ultime partecipazioni dichiarate
US:PRCT / PROCEPT BioRobotics Corporation 10% Owner 2.823.681
US:RETA / Reata Pharmaceuticals Inc - Class A Director, 10% Owner 0
US:APEN / Apollo Endosurgery Inc 10% Owner 0
Come interpretare i grafici

I grafici seguenti mostrano l'andamento dei titoli dopo ogni operazione di mercato aperto non pianificata effettuata da CPMG Inc. Per operazioni non pianificate si intendono operazioni non effettuate nell'ambito di un piano di trading 10b5-1. La performance dei titoli è rappresentata come variazione percentuale cumulativa del prezzo delle azioni. Ad esempio, se un'operazione di insider è stata effettuata il 1° gennaio 2019, il grafico mostrerà la variazione percentuale giornaliera del titolo fino ad oggi. Se il prezzo dell'azione passasse da 10 a 15 dollari durante questo periodo, la variazione percentuale cumulativa del prezzo dell'azione sarebbe del 50%. Una variazione di prezzo da 10 a 20 dollari sarebbe del 100%, mentre una variazione di prezzo da 10 a 5 dollari sarebbe del -50%.

In definitiva, cerchiamo di determinare la correlazione tra le operazioni dell'insider e i rendimenti in eccesso (positivi o negativi) del prezzo dell'azione, al fine di capire se l'insider sta programmando le proprie operazioni per trarre profitto da informazioni privilegiate. Immaginiamo che un insider stia facendo questo. In questa situazione, ci aspetteremmo (a) rendimenti positivi dopo gli acquisti, oppure (b) rendimenti negativi dopo le vendite. Nel caso (a), il grafico ACQUISTO mostrerebbe una serie di curve ascendenti, indicando rendimenti positivi dopo ogni operazione di acquisto. Nel caso (b), il grafico VENDITA mostrerebbe una serie di curve inclinate verso il basso, indicando rendimenti negativi dopo ogni operazione di vendita.

Tuttavia, questo non è sufficiente per trarre conclusioni. Se, ad esempio, il prezzo delle azioni della società è aumentato in maniera non ciclica per molti anni, allora ci aspetteremmo che tutti i grafici post-acquisto abbiano una pendenza rivolta verso l'alto. Allo stesso modo, ribassi non ciclici per molti anni darebbero luogo a grafici post-negoziazione rivolti verso il basso. Nessuno di questi grafici suggerisce un'attività di insider trading.

L'indicatore più forte sarebbe una situazione in cui il prezzo delle azioni fosse estremamente ciclico e vi fossero segnali positivi nel grafico ACQUISTO e curve negative nel grafico VENDITA. Questa situazione suggerirebbe che l'insider sta programmando le operazioni di trading per trarne un vantaggio finanziario.

Acquisti di insider PRCT / PROCEPT BioRobotics Corporation - Analisi degli utili a breve termine

In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in PRCT / PROCEPT BioRobotics Corporation. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
massimo
Prezzo al
massimo
Profitto
massimo ($)
Rendimento massimo (%)
2021-09-17 PRCT CPMG Inc 440.000 25,0000 440.000 25,0000 11.000.000 357 50.6500 11.286.000 102,60

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

PRCT / PROCEPT BioRobotics Corporation Insider Trades
Vendite di insider PRCT / PROCEPT BioRobotics Corporation - Analisi delle perdite a breve termine

In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in PRCT / PROCEPT BioRobotics Corporation. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
minimo
Prezzo al
minimo
Perdita massima
evitata ($)
Perdita massima
evitata (%)
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli.

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

PRCT / PROCEPT BioRobotics Corporation Insider Trades
Storico delle operazioni degli insider

Questa tabella mostra l'elenco completo delle operazioni effettuate da CPMG Inc come comunicato alla Securities Exchange Commission (SEC).

Data di deposito Data della transazione Modulo Ticker Titolo Codice 10b5-1 Azioni Azioni rimanenti Variazione
percentuale
Prezzo
dell'azione
Valore
della transazione
Valore
rimanente
2024-05-07 2024-05-03 4 PRCT PROCEPT BioRobotics Corp
Common Stock
J - Other -1.785.127 2.823.681 -38,73
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -134 0 -100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -11.076 0 -100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -160.265 0 -100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -334.740 0 -100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -37.909 0 -100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -109.415 0 -100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -431.155 0 -100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -748.253 0 -100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -442.560 0 -100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -34.897 0 -100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -44.200 0 -100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -5.464 0 -100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -137.962 0 -100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -282.246 0 -100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -116.512 0 -100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -113 0 -100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer -31.467 0 -100,00
2023-04-04 2023-04-04 4 APEN Apollo Endosurgery, Inc.
Common Stock
D - Sale to Issuer -400.675 0 -100,00
2023-04-04 2023-04-04 4 APEN Apollo Endosurgery, Inc.
Common Stock
D - Sale to Issuer -63.671 0 -100,00
2023-04-04 2023-04-04 4 APEN Apollo Endosurgery, Inc.
Common Stock
D - Sale to Issuer -45.594 0 -100,00
2023-04-04 2023-04-04 4 APEN Apollo Endosurgery, Inc.
Common Stock
D - Sale to Issuer -3.687.781 0 -100,00
2023-04-04 2023-04-04 4 APEN Apollo Endosurgery, Inc.
Common Stock
D - Sale to Issuer -1.310.701 0 -100,00
2023-04-04 2023-04-04 4 APEN Apollo Endosurgery, Inc.
Common Stock
D - Sale to Issuer -675.181 0 -100,00
2022-12-30 2022-12-28 4 APEN Apollo Endosurgery, Inc.
Class A common stock
C - Conversion 1.465.770 3.687.781 65,97 3,25 4.763.752 11.985.288
2022-12-30 2022-12-28 4 APEN Apollo Endosurgery, Inc.
Class A common stock
C - Conversion 586.308 1.310.701 80,94 3,25 1.905.501 4.259.778
2022-12-30 2022-12-28 4 APEN Apollo Endosurgery, Inc.
Class A common stock
C - Conversion 146.577 675.181 27,73 3,25 476.375 2.194.338
2022-12-07 2022-12-05 4 PRCT PROCEPT BioRobotics Corp
Common Stock
J - Other -1.726.534 5.029.869 -25,55
2022-11-16 2022-11-14 4 PRCT PROCEPT BioRobotics Corp
Common Stock
J - Other -1.729.482 6.993.137 -19,83
2022-09-13 2022-09-09 4 PRCT PROCEPT BioRobotics Corp
Common Stock
J - Other -986.640 8.955.675 -9,92
2022-09-08 2022-09-06 4 PRCT PROCEPT BioRobotics Corp
Common Stock
J - Other -743.021 10.075.491 -6,87
2022-03-21 2022-03-17 4 PRCT PROCEPT BioRobotics Corp
Common Stock
J - Other -304.268 10.918.394 -2,71
2021-10-19 2021-10-15 4 APEN Apollo Endosurgery, Inc.
Class A common stock
P - Purchase 387.097 2.151.209 21,94 7,75 3.000.002 16.671.870
2021-10-19 2021-10-15 4 APEN Apollo Endosurgery, Inc.
Class A common stock
P - Purchase 258.064 696.071 58,92 7,75 1.999.996 5.394.550
2021-10-19 2021-10-15 4 APEN Apollo Endosurgery, Inc.
Class A common stock
P - Purchase 38.710 521.522 8,02 7,75 300.002 4.041.796
2021-09-21 2021-09-17 4 PRCT PROCEPT BioRobotics Corp
Series G Convertible Preferred Stock
C - Conversion -272.205 0 -100,00
2021-09-21 2021-09-17 4 PRCT PROCEPT BioRobotics Corp
Series F Convertible Preferred Stock
C - Conversion -2.060.802 0 -100,00
2021-09-21 2021-09-17 4 PRCT PROCEPT BioRobotics Corp
Series E Convertible Preferred Stock
C - Conversion -3.038.934 0 -100,00
2021-09-21 2021-09-17 4 PRCT PROCEPT BioRobotics Corp
Series D Convertible Preferred Stock
C - Conversion -4.712.969 0 -100,00
2021-09-21 2021-09-17 4 PRCT PROCEPT BioRobotics Corp
Common Stock
P - Purchase 440.000 11.222.662 4,08 25,00 11.000.000 280.566.550
2021-09-21 2021-09-17 4 PRCT PROCEPT BioRobotics Corp
Common Stock
C - Conversion 10.084.910 10.782.662 1.445,34
2021-09-14 3 PRCT PROCEPT BioRobotics Corp
Common Stock
697.752
2020-12-29 2020-12-23 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
J - Other -103.185 0 -100,00
2020-12-29 2020-12-23 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
J - Other -63.481 0 -100,00
2020-07-21 2020-07-17 4 APEN Apollo Endosurgery, Inc.
Class A common stock
P - Purchase 1.200.000 1.707.208 236,59 1,25 1.500.000 2.134.010
2020-07-21 2020-07-17 4 APEN Apollo Endosurgery, Inc.
Class A common stock
P - Purchase 400.000 415.244 2.623,98 1,25 500.000 519.055
2020-07-21 2020-07-17 4 APEN Apollo Endosurgery, Inc.
Class A common stock
P - Purchase 180.000 477.120 60,58 1,25 225.000 596.400
2020-01-06 2020-01-02 4 APEN Apollo Endosurgery, Inc.
Class A common stock
J - Other 38.108 507.208 8,12
2020-01-06 2020-01-02 4 APEN Apollo Endosurgery, Inc.
Class A common stock
J - Other 15.244 15.244
2020-01-06 2020-01-02 4 APEN Apollo Endosurgery, Inc.
Class A common stock
J - Other 3.811 297.120 1,30
2019-11-18 2019-11-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 5.464 5.464 183,00 999.912 999.912
2019-11-18 2019-11-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 27.322 137.962 24,69 183,00 4.999.926 25.247.046
2019-11-18 2019-11-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 328 282.246 0,12 183,00 60.024 51.651.018
2019-11-18 2019-11-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 7.104 116.512 6,49 183,00 1.300.032 21.321.696
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1.317.943
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1.565.658
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1.336.020
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1.673.024
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1.741.449
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1.317.943
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1.565.658
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1.336.020
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1.673.024
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1.741.449
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1.317.943
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1.565.658
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1.336.020
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1.673.024
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1.741.449
2018-12-12 2018-12-12 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1.418 281.918 0,51 59,90 84.931 16.885.535
2018-12-12 2018-12-11 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 52.809 109.408 93,30 60,07 3.172.337 6.572.346
2018-12-12 2018-12-10 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 29.347 56.599 107,69 59,53 1.747.036 3.369.355
2018-12-12 2018-12-10 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1.078 27.252 4,12 58,62 63.194 1.597.561
2018-12-12 2018-12-10 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 26.174 26.174 57,93 1.516.336 1.516.336
2017-12-29 2017-12-29 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 17.000 44.200 62,50 28,47 484.016 1.258.440
2017-12-28 2017-12-28 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 200 27.200 0,74 26,10 5.220 709.920
2017-12-28 2017-12-27 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 15.000 27.000 125,00 25,83 387.444 697.399
2017-12-28 2017-12-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 12.000 12.000 26,06 312.726 312.726
2017-12-28 2017-12-14 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 14.866 34.897 74,21 24,65 366.489 860.309
2017-12-28 2017-12-13 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 49 20.031 0,25 23,98 1.175 480.277
2017-12-28 2017-12-13 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 19.982 19.982 24,88 497.228 497.228
2017-12-15 2017-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 37.492 431.155 9,52 24,65 924.283 10.629.178
2017-12-15 2017-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 6.245 103.185 6,44 24,65 153.957 2.543.799
2017-12-15 2017-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 19.672 748.253 2,70 24,65 484.970 18.446.532
2017-12-15 2017-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 14.866 477.457 3,21 24,65 366.489 11.770.652
2017-12-15 2017-12-13 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 148 393.663 0,04 23,98 3.549 9.438.740
2017-12-15 2017-12-13 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 59.982 393.515 17,98 24,88 1.492.580 9.792.149
2017-12-15 2017-12-13 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 25 96.940 0,03 23,98 599 2.324.301
2017-12-15 2017-12-13 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 9.990 96.915 11,49 24,88 248.589 2.411.613
2017-12-15 2017-12-13 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 78 728.581 0,01 23,98 1.870 17.468.968
2017-12-15 2017-12-13 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 31.471 728.503 4,52 24,88 783.118 18.127.923
2017-12-15 2017-12-13 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 49 462.591 0,01 23,98 1.175 11.091.406
2017-12-15 2017-12-13 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 19.982 462.542 4,52 24,88 497.228 11.509.803
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
C - Conversion -110.640 0 -100,00
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
C - Conversion -33.656 0 -100,00
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
C - Conversion -386.285 0 -100,00
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
C - Conversion -211.708 0 -100,00
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
P - Purchase 110.640 110.640 25,00 2.766.000 2.766.000
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
P - Purchase 33.656 33.656 25,00 841.400 841.400
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
P - Purchase 386.285 386.285 25,00 9.657.125 9.657.125
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
P - Purchase 211.708 211.708 25,00 5.292.700 5.292.700
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
P - Purchase 355.591 993.929 55,71 25,00 8.889.775 24.848.225
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
P - Purchase 102.120 114.946 796,20 25,00 2.553.000 2.873.650
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 110.640 110.640
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 33.656 86.925 63,18
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 386.285 697.032 124,31
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 211.708 442.560 91,71
2017-01-04 2016-12-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2.510 334.740 0,76 21,72 54.529 7.272.126
2017-01-04 2016-12-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2.810 310.747 0,91 21,72 61.046 6.750.885
2017-01-04 2016-12-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1.730 230.852 0,76 21,72 37.584 5.015.190
2017-01-04 2016-12-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 480 63.481 0,76 21,72 10.428 1.379.106
2017-01-04 2016-12-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 220 37.909 0,58 21,72 4.779 823.562
2017-01-04 2016-12-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 512 333.533 0,15 21,72 11.123 7.245.904
2017-01-04 2016-12-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1.130 109.415 1,04 21,72 24.549 2.377.008
2016-12-20 2016-12-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 42.110 332.230 14,51 22,99 968.147 7.638.267
2016-12-20 2016-12-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 64.250 307.937 26,37 22,99 1.477.165 7.079.749
2016-12-20 2016-12-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 29.040 229.122 14,51 22,99 667.656 5.267.721
2016-12-20 2016-12-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 7.990 63.001 14,52 22,99 183.697 1.448.450
2016-12-20 2016-12-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1.330 37.689 3,66 22,99 30.578 866.504
2016-12-20 2016-12-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 20.033 280.500 7,69 22,99 460.577 6.448.947
2016-12-16 2016-12-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 579 290.120 0,20 22,05 12.767 6.397.088
2016-12-16 2016-12-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1.290 243.687 0,53 22,05 28.444 5.373.250
2016-12-16 2016-12-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 400 200.082 0,20 22,05 8.820 4.411.768
2016-12-16 2016-12-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 110 55.011 0,20 22,05 2.425 1.212.982
2016-12-16 2016-12-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 321 260.467 0,12 22,05 7.078 5.743.245
2016-12-16 2016-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1.439 289.541 0,50 21,37 30.744 6.186.072
2016-12-16 2016-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2.810 242.397 1,17 21,37 60.036 5.178.836
2016-12-16 2016-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1.000 199.682 0,50 21,37 21.365 4.266.226
2016-12-16 2016-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 270 54.901 0,49 21,37 5.769 1.172.965
2016-12-16 2016-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 670 260.146 0,26 21,37 14.315 5.558.045
2016-08-18 2016-08-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 34.130 288.102 13,44 17,32 591.234 4.990.791
2016-08-18 2016-08-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 35.490 239.587 17,39 17,32 614.793 4.150.366
2016-08-18 2016-08-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 23.530 198.682 13,43 17,32 407.610 3.441.768
2016-08-18 2016-08-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 4.120 108.285 3,96 17,32 71.371 1.875.821
2016-08-18 2016-08-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 6.470 54.631 13,43 17,32 112.080 946.373
2016-08-18 2016-08-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1.822 36.359 5,28 17,32 31.563 629.847
2016-08-18 2016-08-17 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 46.510 253.972 22,42 17,26 802.884 4.384.217
2016-08-18 2016-08-17 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 48.320 204.097 31,02 17,26 834.129 3.523.245
2016-08-18 2016-08-17 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 32.080 175.152 22,42 17,26 553.784 3.023.579
2016-08-18 2016-08-17 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 5.830 104.165 5,93 17,26 100.641 1.798.159
2016-08-18 2016-08-17 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 8.820 48.161 22,42 17,26 152.256 831.384
2016-08-18 2016-08-17 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2.498 34.537 7,80 17,26 43.122 596.198
2016-08-18 2016-08-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 18.620 207.462 9,86 16,21 301.845 3.363.125
2016-08-18 2016-08-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 19.050 155.777 13,93 16,21 308.816 2.525.270
2016-08-18 2016-08-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 12.840 143.072 9,86 16,21 208.147 2.319.312
2016-08-18 2016-08-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 3.460 98.335 3,65 16,21 56.089 1.594.089
2016-08-18 2016-08-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 3.530 39.341 9,86 16,21 57.224 637.749
2016-08-18 2016-08-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1.100 32.039 3,56 16,21 17.832 519.378
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 99.922 99.922 11,00 1.099.142 1.099.142
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 72.357 72.357 11,00 795.927 795.927
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 68.912 68.912 11,00 758.032 758.032
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 18.951 18.951 11,00 208.461 208.461
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 16.366 16.366 11,00 180.026 180.026
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 53.119 53.119 11,00 584.309 584.309
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 275.047 332.396 479,60 11,00 3.025.517 3.656.356
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 64.712 78.205 479,60 11,00 711.832 860.255
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 132.614 160.265 479,60 11,00 1.458.754 1.762.915
2016-06-30 2016-06-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 34.010 88.920 61,94 19,75 671.735 1.756.268
2016-06-30 2016-06-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 24.630 64.370 61,98 19,75 486.470 1.271.378
2016-06-30 2016-06-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 23.460 61.320 61,97 19,75 463.361 1.211.137
2016-06-30 2016-06-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 5.880 30.163 24,21 19,75 116.136 595.752
2016-06-30 2016-06-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 6.450 16.860 61,96 19,75 127.395 333.004
2016-06-30 2016-06-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 5.570 14.573 61,87 19,75 110.014 287.833
2016-06-30 2016-06-29 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 21.690 54.910 65,29 19,83 430.074 1.088.766
2016-06-30 2016-06-29 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 15.700 39.740 65,31 19,83 311.303 787.973
2016-06-30 2016-06-29 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 14.960 37.860 65,33 19,83 296.630 750.696
2016-06-30 2016-06-29 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 3.690 24.283 17,92 19,83 73.166 481.488
2016-06-30 2016-06-29 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 4.110 10.410 65,24 19,83 81.494 206.412
2016-06-30 2016-06-29 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 3.550 9.003 65,10 19,83 70.390 178.513
2016-06-30 2016-06-28 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 310 33.220 0,94 19,74 6.119 655.670
2016-06-30 2016-06-28 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 220 24.040 0,92 19,74 4.342 474.482
2016-06-30 2016-06-28 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 210 22.900 0,93 19,74 4.145 451.982
2016-06-30 2016-06-28 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 50 20.593 0,24 19,74 987 406.448
2016-06-30 2016-06-28 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 50 20.593 0,24 19,74 987 406.448
2016-06-30 2016-06-28 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 60 6.300 0,96 19,74 1.184 124.344
2016-06-28 2016-06-27 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 6.770 259.476 2,68 19,17 129.814 4.975.426
2016-06-28 2016-06-27 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 5.130 32.190 18,96 19,17 98.367 617.240
2016-06-28 2016-06-27 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 3.720 23.820 18,51 19,17 71.331 456.746
2016-06-28 2016-06-27 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 3.540 22.690 18,49 19,17 67.879 435.078
2016-06-28 2016-06-27 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 990 20.543 5,06 19,17 18.983 393.910
2016-06-28 2016-06-27 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 970 6.240 18,41 19,17 18.600 119.651
2016-06-28 2016-06-27 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 848 5.403 18,62 19,17 16.260 103.602
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 14.386 27.780 107,41 19,49 280.390 541.446
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 10.418 20.100 107,60 19,49 203.052 391.759
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 9.921 19.150 107,50 19,49 193.365 373.243
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2.712 19.553 16,10 19,49 52.858 381.098
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2.728 5.270 107,32 19,49 53.170 102.715
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2.360 4.555 107,52 19,49 45.998 88.779
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 3.014 13.394 29,04 18,35 55.307 245.781
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2.182 9.682 29,09 18,35 40.040 177.666
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2.079 9.229 29,08 18,35 38.150 169.353
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 568 16.841 3,49 18,35 10.423 309.034
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 572 2.542 29,04 18,35 10.496 46.646
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 495 2.195 29,12 18,35 9.083 40.278
2016-06-08 2016-06-07 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1.400 10.380 15,59 17,62 24.669 182.905
2016-06-08 2016-06-07 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1.010 7.500 15,56 17,62 17.797 132.157
2016-06-08 2016-06-07 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 970 7.150 15,70 17,62 17.092 125.989
2016-06-08 2016-06-07 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 340 16.273 2,13 17,62 5.991 286.745
2016-06-08 2016-06-07 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 270 1.970 15,88 17,62 4.758 34.713
2016-06-08 2016-06-07 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 230 1.700 15,65 17,62 4.053 29.956
2016-06-08 2016-06-06 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 6.650 8.980 285,41 17,56 116.771 157.685
2016-06-08 2016-06-06 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 4.810 6.490 286,31 17,56 84.462 113.962
2016-06-08 2016-06-06 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 4.580 6.180 286,25 17,56 80.423 108.518
2016-06-08 2016-06-06 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1.610 15.933 11,24 17,56 28.271 279.777
2016-06-08 2016-06-06 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1.260 1.700 286,36 17,56 22.125 29.851
2016-06-08 2016-06-06 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1.090 1.470 286,84 17,56 19.140 25.813
2016-06-03 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 625 57.974 1,09 13,42 8.387 778.005
2016-06-03 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 830 14.323 6,15 13,42 11.139 192.213
2016-06-03 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2.330 2.330 13,42 31.268 31.268
2016-06-03 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1.680 1.680 13,42 22.545 22.545
2016-06-03 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1.600 1.600 13,42 21.472 21.472
2016-06-03 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 440 440 13,42 5.905 5.905
2016-06-03 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 380 380 13,42 5.100 5.100
2016-06-03 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 150 150 13,42 2.013 2.013
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion -134 1.490 -8,25
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion -57.349 638.338 -8,24
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion -13.493 150.186 -8,24
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion -11.076 123.279 -8,24
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion -1.153 12.826 -8,25
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion -27.651 307.776 -8,24
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion -113 1.251 -8,28
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 23.890 252.706 10,44 14,11 336.997 3.564.721
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 6.203 228.816 2,79 14,22 88.218 3.254.198
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 28.797 222.613 14,86 13,26 381.989 2.952.939
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 8.233 193.816 4,44 13,22 108.815 2.561.647
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 127.691 185.583 220,57 12,76 1.629.899 2.368.856
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 56.739 57.892 4.920,99 11,43 648.305 661.480
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 134 134
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 57.349 57.349
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 13.493 13.493
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 11.076 11.076
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 1.153 1.153
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 27.651 27.651
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 113 113
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)